🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/10/1986 | 5,41 | 5,43 | 5,39 | 5,42 | +0,00% | 0,73% | 3.055.968 |
| 10/10/1986 | 5,47 | 5,50 | 5,39 | 5,42 | -1,21% | 2,06% | 4.953.686 |
| 09/10/1986 | 5,40 | 5,53 | 5,39 | 5,49 | +1,22% | 2,45% | 6.442.056 |
| 08/10/1986 | 5,38 | 5,46 | 5,37 | 5,42 | +0,25% | 1,60% | 4.450.018 |
| 07/10/1986 | 5,41 | 5,43 | 5,35 | 5,41 | +0,74% | 1,59% | 4.700.909 |
| 06/10/1986 | 5,32 | 5,39 | 5,29 | 5,37 | +1,38% | 1,99% | 3.631.320 |
| 03/10/1986 | 5,41 | 5,45 | 5,26 | 5,29 | -0,87% | 3,43% | 9.567.821 |
| 02/10/1986 | 5,29 | 5,35 | 5,28 | 5,34 | +0,37% | 1,38% | 5.200.805 |
| 01/10/1986 | 5,23 | 5,37 | 5,22 | 5,32 | +1,90% | 2,91% | 5.719.565 |
| 30/09/1986 | 5,27 | 5,34 | 5,20 | 5,22 | -0,75% | 2,76% | 5.853.499 |
| 29/09/1986 | 5,26 | 5,27 | 5,18 | 5,26 | -0,13% | 1,76% | 6.130.800 |
| 26/09/1986 | 5,29 | 5,35 | 5,22 | 5,27 | -0,13% | 2,51% | 4.804.661 |
| 25/09/1986 | 5,41 | 5,41 | 5,27 | 5,27 | -3,05% | 2,45% | 6.679.742 |
| 24/09/1986 | 5,33 | 5,45 | 5,29 | 5,44 | +2,88% | 2,99% | 9.452.750 |
| 23/09/1986 | 5,20 | 5,29 | 5,20 | 5,29 | +2,05% | 1,78% | 7.004.203 |
| 22/09/1986 | 5,20 | 5,20 | 5,14 | 5,18 | +0,26% | 1,02% | 5.613.926 |
| 19/09/1986 | 5,20 | 5,22 | 5,17 | 5,17 | -1,51% | 1,02% | 10.473.293 |
| 18/09/1986 | 5,20 | 5,29 | 5,18 | 5,25 | +1,02% | 2,04% | 7.466.371 |
| 17/09/1986 | 5,30 | 5,31 | 5,18 | 5,20 | -1,75% | 2,50% | 10.744.934 |
| 16/09/1986 | 5,23 | 5,29 | 5,17 | 5,29 | +0,50% | 2,28% | 8.351.093 |
| 15/09/1986 | 5,23 | 5,31 | 5,20 | 5,26 | +0,89% | 2,16% | 8.622.734 |
| 12/09/1986 | 5,30 | 5,33 | 5,17 | 5,22 | -1,38% | 3,00% | 18.024.552 |
| 11/09/1986 | 5,53 | 5,53 | 5,25 | 5,29 | -4,66% | 5,15% | 13.042.570 |
| 10/09/1986 | 5,53 | 5,56 | 5,47 | 5,55 | +0,36% | 1,68% | 6.085.526 |
| 09/09/1986 | 5,63 | 5,67 | 5,50 | 5,53 | -0,72% | 3,06% | 10.128.082 |
| 08/09/1986 | 5,73 | 5,73 | 5,54 | 5,57 | -4,87% | 3,35% | 18.864.000 |
| 05/09/1986 | 5,98 | 6,00 | 5,80 | 5,85 | -2,86% | 3,33% | 9.424.454 |
| 04/09/1986 | 5,95 | 6,08 | 5,91 | 6,02 | +1,45% | 2,90% | 9.814.939 |
| 03/09/1986 | 5,88 | 5,99 | 5,86 | 5,94 | +1,01% | 2,14% | 7.368.278 |
| 02/09/1986 | 6,12 | 6,13 | 5,84 | 5,88 | -4,11% | 4,65% | 7.709.717 |